Evommune EVMN Weighted Average Number Of Shares Dilutive Effect Of Series A Preferred Stock
Weighted Average Number Of Shares Dilutive Effect Of Series A Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:WeightedAverageNumberOfSharesDilutiveEffectOfSeriesAPreferredStock.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's weighted average number of shares dilutive effect of series a preferred stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's weighted average number of shares dilutive effect of series a preferred stock?
- Evommune (EVMN) reported weighted average number of shares dilutive effect of series a preferred stock of 61.6M in Q4 2025.
- What does weighted average number of shares dilutive effect of series a preferred stock mean?
- The incremental number of shares that would be issued upon the conversion of Series A preferred stock, factored into the calculation of diluted earnings per share. This reflects the potential ownership dilution impact specifically attributable to the Series A preferred equity class.